InvestorsHub Logo
Followers 113
Posts 17424
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Wednesday, 03/27/2024 7:32:38 AM

Wednesday, March 27, 2024 7:32:38 AM

Post# of 553
METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVCR News